Philip H Coelho - Net Worth and Insider Trading
Philip H Coelho Net Worth
The estimated net worth of Philip H Coelho is at least $3 Million dollars as of 2024-12-11. Philip H Coelho is the Director of Catalyst Pharmaceuticals Inc and owns about 149,553 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $3 Million. Philip H Coelho is the Director of Ampio Pharmaceuticals Inc and owns about 678 shares of Ampio Pharmaceuticals Inc (AMPE) stock worth over $0. Philip H Coelho is also the CEO of ThermoGenesis Holdings Inc and owns about 3 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $0. Details can be seen in Philip H Coelho's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Philip H Coelho has not made any transactions after 2022-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Philip H Coelho
Philip H Coelho Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Philip H Coelho owns 3 companies in total, including Ampio Pharmaceuticals Inc (AMPE) , Catalyst Pharmaceuticals Inc (CPRX) , and ThermoGenesis Holdings Inc (THMO) .
Click here to see the complete history of Philip H Coelho’s form 4 insider trades.
Insider Ownership Summary of Philip H Coelho
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMPE | Ampio Pharmaceuticals Inc | 2021-04-29 | director |
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-23 | director |
| THMO | ThermoGenesis Holdings Inc | 2006-05-12 | director & Chief Executive Officer |
Philip H Coelho Latest Holdings Summary
Philip H Coelho currently owns a total of 3 stocks. Among these stocks, Philip H Coelho owns 149,553 shares of Catalyst Pharmaceuticals Inc (CPRX) as of November 23, 2022, with a value of $3 Million and a weighting of 100%. Philip H Coelho owns 678 shares of Ampio Pharmaceuticals Inc (AMPE) as of April 29, 2021, with a value of $0 and a weighting of 0%. Philip H Coelho also owns 3 shares of ThermoGenesis Holdings Inc (THMO) as of May 12, 2006, with a value of $0 and a weighting of 0%.
Latest Holdings of Philip H Coelho
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-23 | 149,553 | 21.88 | 3,272,205 |
| AMPE | Ampio Pharmaceuticals Inc | 2021-04-29 | 678 | 0.00 | 0 |
| THMO | ThermoGenesis Holdings Inc | 2006-05-12 | 3 | 0.00 | 0 |
Holding Weightings of Philip H Coelho
Philip H Coelho Form 4 Trading Tracker
According to the SEC Form 4 filings, Philip H Coelho has made a total of 3 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 100,000 shares on November 23, 2022, which brought Philip H Coelho around $2 Million.
According to the SEC Form 4 filings, Philip H Coelho has made a total of 2 transactions in Ampio Pharmaceuticals Inc (AMPE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Ampio Pharmaceuticals Inc is the sale of 11 shares on April 29, 2021, which brought Philip H Coelho around $6,526.
According to the SEC Form 4 filings, Philip H Coelho has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the acquisition of 1 shares on May 12, 2006, which cost Philip H Coelho around $100,250.
Insider Trading History of Philip H Coelho
- 1
Philip H Coelho Trading Performance
GuruFocus tracks the stock performance after each of Philip H Coelho's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Philip H Coelho is 102.96%. GuruFocus also compares Philip H Coelho's trading performance to market benchmark return within the same time period. The performance of stocks bought by Philip H Coelho within 3 months outperforms 11 times out of 15 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Philip H Coelho's insider trading performs compared to the benchmark.
Performance of Philip H Coelho
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 32.1 | | | | | |
| Relative Return to S&P 500(%) | 31.01 | | | | | |
Philip H Coelho Ownership Network
Ownership Network List of Philip H Coelho
Ownership Network Relation of Philip H Coelho
Philip H Coelho Owned Company Details
What does Ampio Pharmaceuticals Inc do?
Who are the key executives at Ampio Pharmaceuticals Inc?
Philip H Coelho is the director of Ampio Pharmaceuticals Inc. Other key executives at Ampio Pharmaceuticals Inc include Chief Operating Officer Holli Cherevka , CFO Dan Stokely , and Chief Financial Officer Chilcott, Iii Thomas E. .
Ampio Pharmaceuticals Inc (AMPE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ampio Pharmaceuticals Inc (AMPE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ampio Pharmaceuticals Inc (AMPE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ampio Pharmaceuticals Inc (AMPE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ampio Pharmaceuticals Inc Insider Transactions
Philip H Coelho Mailing Address
Above is the net worth, insider trading, and ownership report for Philip H Coelho. You might contact Philip H Coelho via mailing address: C/o Thermogenesis Corp, 2711 Citrus Road, Rancho Cordova Ca 95742.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
